Literature DB >> 17381447

Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing the Na(v)1.3 alpha-subunit.

Guang-chun Sun1, Taco R Werkman, Arne Battefeld, Jeffrey J Clare, Wytse J Wadman.   

Abstract

PURPOSE: The transient and the persistent Na(+) current play a distinct role in neuronal excitability. Several antiepileptic drugs (AEDs) modulate the transient Na(+) current and block the persistent Na(+) current; both effects contribute to their antiepileptic properties. The interactions of the AEDs carbamazepine (CBZ) and topiramate (TPM) with the persistent and transient Na(+) current were investigated.
METHODS: HEK293 cells stably expressing the alpha-subunit of the Na(+) channel Na(V)1.3 were used to record Na(+) currents under voltage-clamp by using the patch-clamp technique in whole-cell configuration and to investigate the effects of CBZ and TPM.
RESULTS: The persistent Na(+) current was present in all cells and constituted 10.3 +/- 3.8% of the total current. CBZ partially blocked the persistent Na(+) current in a concentration-dependent manner [median effective concentration (EC(50)), 16 +/- 4 microM]. CBZ also shifted the steady-state inactivation of the transient Na(+) current to negative potentials (EC(50), 14 +/- 11 microM). TPM partially blocked the persistent Na(+) current with a much higher affinity (EC(50), 61 +/- 37 nM) than it affected the steady-state inactivation of the transient Na(+) current (EC(50), 3.2 +/- 1.8 microM). For the latter effect, TPM was at most half as effective as CBZ.
CONCLUSIONS: The persistent Na(+) current flowing through the alpha-subunit of the Na(V)1.3 channel is partially blocked by CBZ at about the same therapeutic concentrations at which it modulates the transient Na(+) current, adding a distinct aspect to its anticonvulsant profile. The TPM-induced partial block of the persistent Na(+) current, already effective at low concentrations, could be the dominant action of this drug on the Na(+) current.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17381447     DOI: 10.1111/j.1528-1167.2007.01001.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  20 in total

1.  Reduction of spike generation frequency by cooling in brain slices from rats and from patients with epilepsy.

Authors:  Sadahiro Nomura; Hiroyuki Kida; Yuya Hirayama; Hirochika Imoto; Takao Inoue; Hiroshi Moriyama; Dai Mitsushima; Michiyasu Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-17       Impact factor: 6.200

Review 2.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

3.  Mutations in SCN3A cause early infantile epileptic encephalopathy.

Authors:  Tariq Zaman; Ingo Helbig; Ivana Babić Božović; Suzanne D DeBrosse; A Christina Bergqvist; Kimberly Wallis; Livija Medne; Aleš Maver; Borut Peterlin; Katherine L Helbig; Xiaohong Zhang; Ethan M Goldberg
Journal:  Ann Neurol       Date:  2018-03-30       Impact factor: 10.422

4.  Novel SCN3A variants associated with focal epilepsy in children.

Authors:  Carlos G Vanoye; Christina A Gurnett; Katherine D Holland; Alfred L George; Jennifer A Kearney
Journal:  Neurobiol Dis       Date:  2013-10-21       Impact factor: 5.996

5.  Antinociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation.

Authors:  Tatsushige Iwamoto; Yoshihiro Takasugi; Hideaki Higashino; Hiroyuki Ito; Yoshihisa Koga; Shinichi Nakao
Journal:  J Anesth       Date:  2010-11-27       Impact factor: 2.078

6.  Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.

Authors:  Eric R Wengert; Anusha U Saga; Payal S Panchal; Bryan S Barker; Manoj K Patel
Journal:  Neuropharmacology       Date:  2019-07-03       Impact factor: 5.250

7.  Properties of human brain sodium channel α-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine.

Authors:  Xin Qiao; Guangchun Sun; Jeffrey J Clare; Taco R Werkman; Wytse J Wadman
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 8.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 9.  Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet.

Authors:  Michael A Rogawski; Wolfgang Löscher; Jong M Rho
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

10.  Differential effects on fast and slow spindle activity, and the sleep slow oscillation in humans with carbamazepine and flunarizine to antagonize voltage-dependent Na+ and Ca2+ channel activity.

Authors:  Amr Ayoub; Dominic Aumann; Anne Hörschelmann; Atossa Kouchekmanesch; Pia Paul; Jan Born; Lisa Marshall
Journal:  Sleep       Date:  2013-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.